Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Carlos Alberto Pastore | Medicine and Health Sciences | Best Researcher Award

Prof. Carlos Alberto Pastore | Medicine and Health Sciences | Best Researcher Award

Heart Institute of the Hospital das Clínicas of FMUSP | Brazil

Prof. Carlos Alberto Pastore is a distinguished cardiologist and researcher from the University of São Paulo, Brazil, internationally recognized for his pioneering work in electrocardiology and vectorcardiography. As a Professor and Medical Collaborator at the Faculty of Medicine, University of São Paulo (FMUSP), he has significantly advanced diagnostic methods for cardiac electrical diseases, cardiac mapping, and non-invasive electrocardiographic techniques. His research specializes in surface electrocardiographic mapping, high-resolution ECG, microalternans of the T wave (mTWA), and vectorcardiographic analysis of ventricular activation and repolarization abnormalities. Prof. Carlos Alberto Pastore has played a vital role in refining diagnostic criteria for arrhythmogenic disorders, ventricular hypertrophy, and cardiac resynchronization therapy, and he has applied artificial neural networks and machine learning in ECG-based cardiopathy detection in collaboration with the Federal University of Technology of Paraná (UTFPR). At InCor – Heart Institute (Hospital das Clínicas, FMUSP), he has held major roles including Director of the Clinical Unit of Resting Electrocardiography, Medical Director of Telemedicine, and Vice-President of the Zerbini Foundation, contributing to translational cardiology and digital health innovation. He also served as President (2013–2015) of the International Society of Electrocardiology (ISE) and is a Fellow of the European Society of Cardiology (FESC). According to Scopus (Author ID: 7006635654), Prof. Carlos Alberto Pastore has authored 53 scientific publications, received 1,014 citations from 948 documents, and holds an h-index of 12. His research has appeared in leading journals including the Journal of Electrocardiology, Annals of Noninvasive Electrocardiology, Arquivos Brasileiros de Cardiologia, and JACC, making him one of Brazil’s leading authorities in clinical electrocardiology and cardiovascular diagnostics.

Profiles: Scopus | Google Scholar | ORCID | ResearchGate

Featured Publications

• de Luna, A. B., Brugada, J., Baranchuk, A., Borggrefe, M., Breithardt, G., & Pastore, C. A. (2012). Current electrocardiographic criteria for diagnosis of Brugada pattern: A consensus report. Journal of Electrocardiology, 45(5), 433–442.* https://doi.org/10.1016/j.jelectrocard.2012.06.004

• de Luna, A. B., Platonov, P., Cosio, F. G., Cygankiewicz, I., Pastore, C., Baranowski, R., … & Spodick, D. (2012). Interatrial blocks: A separate entity from left atrial enlargement: A consensus report. Journal of Electrocardiology, 45(5), 445–451.* https://doi.org/10.1016/j.jelectrocard.2012.06.008

• Pastore, C. A., Pinho, J. A., Pinho, C., Samesima, N., Pereira Filho, H. G., & Mansur, A. P., et al. (2016). III Diretrizes da Sociedade Brasileira de Cardiologia sobre análise e emissão de laudos eletrocardiográficos. Arquivos Brasileiros de Cardiologia, 106(4 Suppl 1), 1–23.* https://doi.org/10.5935/abc.20160054

• Santos, I. S., Goulart, A. C., Brandão, R. M., Santos, R. C. O., Bittencourt, M. S., Sitnik, D., … & Pastore, C. A. (2015). One-year mortality after an acute coronary event and its clinical predictors: The ERICO study. Arquivos Brasileiros de Cardiologia, 105(1), 53–64.* https://doi.org/10.5935/abc.20150049

• Digby, G. C., Kukla, P., Zhan, Z. Q., Pastore, C. A., Piotrowicz, R., Schapachnik, E., … & Baranchuk, A. (2015). The value of electrocardiographic abnormalities in the prognosis of pulmonary embolism: A consensus paper. Annals of Noninvasive Electrocardiology, 20(3), 207–223.* https://doi.org/10.1111/anec.12235

Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Assoc. Prof. Dr. Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Izmir Katip Çelebi University Atatürk Training and Research Hospital | Turkey

Dr. Tuncay Kırış, an Associate Professor at İzmir Kâtip Çelebi University, Izmir, Turkey, is a distinguished cardiology researcher recognized for his extensive contributions to cardiovascular medicine, particularly in the fields of cardiovascular risk prediction, interventional cardiology, acute coronary syndromes, and cardiac biomarkers. His research has provided valuable insights into myocardial infarction, pulmonary embolism, renal complications following cardiac interventions, and the prognostic implications of biochemical and hematological markers in predicting patient outcomes. Dr. Tuncay Kırış has authored 83 peer-reviewed publications in prestigious international journals indexed in SCI and SCI-Expanded, including Angiology, BMC Cardiovascular Disorders, The Anatolian Journal of Cardiology, Clinical and Experimental Hypertension, Herz, and Acta Radiologica. His works have received 591 citations from 544 documents, with an h-index of 15, according to Scopus (Author ID: 55321350600), reflecting his strong academic impact. His studies emphasize innovative predictive and prognostic modeling approaches, such as exploring the fibrinogen-to-albumin ratio, red cell distribution width, and lymphocyte-to-monocyte ratio as novel indicators of adverse cardiovascular events and renal complications. Beyond his research, he has supervised postgraduate theses on cardiovascular risk assessment, contributed to collaborative projects in clinical and translational cardiology, and serves as Editor of the Ege Klinikleri Tıp Dergisi. As an active reviewer for several international cardiology journals, Dr. Tuncay Kırış continues to advance evidence-based cardiology through data-driven research, bridging clinical practice with innovation to improve patient outcomes and global cardiovascular health.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Yildirim, S. E., Yildirim, T., Kırış, T., & Avci, E. (2025, October). Prognostic value of the NAPLES score and serum uric acid in chronic coronary syndrome: Evidence from time-dependent ROC and time-varying hazard ratio analyses. Journal of Clinical Medicine, 14(20), 7416. https://doi.org/10.3390/jcm14207416

  • Tiryaki, M. M., Yılmaz, C., Ince, H. S., Karaca, B., Kayaalti Esin, F., & Kırış, T. (2025, September). Neutrophil percentage-to-albumin ratio as a predictor of in-hospital mortality in infective endocarditis. Biomarkers in Medicine, 19(17), 1–8. https://doi.org/10.1080/17520363.2025.2562554

  • Akkan, G., Kırış, T., Esin, F., & Karaca, M. (2025, May). Evaluation of mortality and hospitalization due to decompensated heart failure and appropriate shocks in reduced ejection fraction in patients with an implantable cardioverter–defibrillator according to a novel tissue Doppler echocardiographic method. Journal of Clinical Medicine, 14(9), 3226. https://doi.org/10.3390/jcm14093226

  • Esin, F., Bozkurt, H., Palac, B., Akar, B., Kırış, T., Özdemir, E., & Karaca, M. (2025, February). The impact of pleural effusion on long-term mortality in patients undergoing transcatheter aortic valve implantation. Journal of Clinical Medicine, 14(5), 1596. https://doi.org/10.3390/jcm14051596

  • Usta, A., Sancakli Usta, C., Lafci, D., Kırış, T., & Avci, E. (2024, December). Contrast induced nephropathy in women with infertility undergoing hysterosalpingography. Reproductive Biology and Endocrinology, 22(1). https://doi.org/10.1186/s12958-024-01334-3

Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr. Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

University of Macau | Macau

Dr. Xiaowen Mao, M.D., Ph.D., is an Assistant Professor at the State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, where she leads translational research on cancer biology, immunotherapy, and tumor microenvironment modulation. She earned her Ph.D. in Biomedical Sciences from the University of Hong Kong and her B.Sc. in Clinical Medicine from Shanghai Jiao Tong University, China. Her research focuses on extracellular vesicles, immune homeostasis, metabolic reprogramming in tumors, and hepatocellular carcinoma metastasis, integrating molecular, cellular, and translational approaches. Dr. Xiaowen Mao has led several high-impact projects as principal investigator, funded by the Health and Medical Research Fund, National Natural Science Foundation Young Scientist Fund, and FDCT Innovation and Technology Promotion. Her significant contributions include the development of broadly potent neutralizing antibodies targeting Nidogen 1 to inhibit tumor growth, elucidation of extracellular vesicle-mediated metabolic reprogramming in tumors, and advances in dendritic cell vaccine strategies. She holds a U.S. patent on Nidogen 1 as a diagnostic and therapeutic target for hepatocellular carcinoma, serves as Guest Editor for Frontiers in Endocrinology, and is an ad-hoc reviewer for multiple high-impact journals. According to Scopus, she has 31 publications, 1,114 citations by 1,010 documents, and an h-index of 20. Dr. Xiaowen Mao’s work bridges fundamental research and clinical translation, delivering innovative therapies and advancing precision medicine in oncology, while demonstrating a profound impact on cancer biology, immunotherapy, and translational research.

Profile: Scopus

Featured Publications

  • Xue, T. M., Yeung, C. L. S., Mao, X. W., Tey, S. K., Lo, K. W., Tang, H. N., Yun, J. P., & Yam, J. W. P. (2025). Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models. Journal of Translational Internal Medicine. https://doi.org/10.1515/jtim-2025-0008

  • Xia, L., Li, C. G., Zhao, J., Sun, Q. C., & Mao, X. W.* (2025). Rebalancing immune homeostasis in combating disease: The impact of medicine food homology plants and gut microbiome. Phytomedicine, 136, 156150. https://doi.org/10.1016/j.phymed.2025.156150

  • Chen, Z., Yam, J. W. P., & Mao, X. W.* (2024). The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments. Proteomics, e2300021. https://doi.org/10.1002/pmic.202300021

  • Lee, K. W., Yam, J. W. P., & Mao, X. W.* (2023). Dendritic cell vaccines: A shift from conventional approach to new generations. Cells, 12(2147). https://doi.org/10.3390/cells12172147

  • Li, S., Delvecchio, M., Ramkumar, K., Mao, X. W., Sun, X. D., & Guo, S. Z. (2023). Editorial: Clinical and genetic determinants of diabetes and complications. Frontiers in Endocrinology.

Oguz Ozcelik | Medicine and Health Sciences | Best Researcher Award

Prof. Dr. Oguz Ozcelik | Medicine and Health Sciences | Best Researcher Award

Kastamonu University | Turkey

Dr. Oğuz Özçelik (MD, PhD) is a distinguished Professor at Kastamonu University, Turkey, widely recognized for his pioneering work in exercise physiology, metabolism, and oxidative stress. His academic foundation in medicine and physiology has driven decades of impactful research exploring the complex relationships between aerobic fitness, respiratory regulation, and metabolic health. Through rigorous experimental design and translational insights, he has advanced understanding of how exercise modulates physiological and biochemical responses in both healthy and clinical populations. Dr. Oğuz Özçelik’s scientific contributions span more than forty peer-reviewed publications in international journals, reflecting depth, innovation, and clinical relevance. His notable works include studies on the relationship between aerobic fitness levels and isocapnic buffering periods during incremental exercise tests (Cellular and Molecular Biology, 2017, cited by 132), the effects of body mass index on maximal work production and aerobic capacity (Physiological Research, 2004, cited by 84), and the role of nesfatin-1 in glucose tolerance and depressive disorders (Physiological Research, 2016; Psychiatry Investigation, 2018). With an h-index of 13 and more than 474 citations, his scholarly influence demonstrates sustained research excellence. Dr. Oğuz Özçelik’s current investigations focus on the hormonal and metabolic adaptations to exercise and their relevance to neuroendocrine and cardiometabolic health. His leadership, academic rigor, and enduring contributions to human performance and biomedical science exemplify the highest standards of professional achievement and research integrity within the global scientific community.

Profile: Scopus | Google Scholar | ORCID

Featured Publications

  1. Algul, S., Ozcelik, O., & Yilmaz, B. (2017). Evaluation of relationship between aerobic fitness level and range of isocapnic buffering periods during incremental exercise test. Cellular and Molecular Biology, 63(3), 78–82.

  2. Ozcelik, O., Aslan, M., Ayar, A., & Kelestimur, H. (2004). Effects of body mass index on maximal work production capacity and aerobic fitness during incremental exercise. Physiological Research, 53(2), 165–170.

  3. Algul, S., Ozkan, Y., & Ozcelik, O. (2016). Serum nesfatin-1 levels in patients with different glucose tolerance levels. Physiological Research, 65(6), 979–985.

  4. Ozcelik, O., Ward, S. A., & Whipp, B. J. (1999). Effect of altered body CO₂ stores on pulmonary gas exchange dynamics during incremental exercise in humans. Experimental Physiology, 84(5), 999–1011.

  5. Algul, S., & Ozcelik, O. (2018). Evaluating the levels of nesfatin-1 and ghrelin hormones in patients with moderate and severe major depressive disorders. Psychiatry Investigation, 15(2), 214–218.

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479

Swaroop S. Sonone | Medicine and Health Sciences | Best Faculty Award

Mr. Swaroop S. Sonone | Medicine and Health Sciences | Best Faculty Award

School of Forensic Sciences, JSPM University, Pune | India

Mr. Swaroop S. Sonone, Assistant Professor at the School of Behavioural and Forensic Sciences, Jayawant Shikshan Prasarak Mandal (JSPM) University, Pune, India, is a distinguished academic and researcher specializing in Digital and Cyber Forensics, Forensic Ballistics, and Cyber Psychology. He holds an M.Sc. in Forensic Science (Digital & Cyber Forensics) and a B.Sc. in Forensic Science from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, along with a Diploma in Photography. He has qualified multiple national eligibility tests, including UGC-NET (three times) and MH-SET (SPPU, 2021), showcasing his academic competence and commitment to higher education. His research credentials, as indexed in Scopus (Author ID: 57219960845; ORCID: 0000-0002-3358-348X), include 24 publications, 670 citations, and an h-index of 5, reflecting his consistent scholarly contribution and scientific impact. Mr. Sonone has demonstrated exemplary academic leadership as Programme Coordinator, IQAC Coordinator, and Editor of the International Journal of Forensic Sciences (IJFSC). His notable publications, such as Water Contamination by Heavy Metals (2020) and Unveiling the Power of Nanoparticles for Latent Fingerprints (2024), highlight his interdisciplinary expertise bridging forensic and environmental sciences. Recognized for his excellence in teaching and research, he received the Young Forensic Faculty Award (NAEF-2025) by ThinkSakshya. Beyond academia, he actively engages in public science communication through national media, fostering forensic awareness. With his intellectual rigor, innovation, and leadership, Mr. Swaroop S. Sonone continues to advance forensic science education and research in India, exemplifying professional excellence and academic integrity.

Profile: Scopus | ORCID | Google Scholar | ResearchGate | LinkedIn | Staff Page

Featured Publications

  • Sonone, S. S., Jadhav, S., Sankhla, M. S., & Kumar, R. (2020). Water contamination by heavy metals and their toxic effect on aquaculture and human health through food chain. Letters in Applied NanoBioScience, 10(2), 2148–2166. Cited by 562.

  • Gulia, S., Rohilla, R. K., Sankhla, M. S., Kumar, R., & Sonone, S. S. (2020). Impact of pesticide toxicity in aquatic environment. Biointerface Research in Applied Chemistry, 11(3), 10131–10140. Cited by 166.

  • Verma, R. K., Sankhla, M. S., Rathod, N. V., Sonone, S. S., Parihar, K., & Singh, G. K. (2022). Eradication of fatal textile industrial dyes by wastewater treatment. Biointerface Research in Applied Chemistry, 12(1), 567–587. Cited by 74.

  • Mohan, H., Rajput, S. S., Jadhav, E. B., Sankhla, M. S., Sonone, S. S., Jadhav, S., et al. (2021). Ecotoxicity, occurrence, and removal of pharmaceuticals and illicit drugs from aquatic systems. Biointerface Research in Applied Chemistry, 11(5), 12530–12546. Cited by 65.

  • Singhal, M., Jadhav, S., Sonone, S. S., Sankhla, M. S., & Kumar, R. (2021). Microalgae-based sustainable bioremediation of water contaminated by pesticides. Biointerface Research in Applied Chemistry, 12, 149–169. Cited by 54.

Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Dr. Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Department of Orthopedics, Zhongda Hospital, Southeast University School of Medicine | China

Dr. Zengxin Gao is a highly accomplished Chief Physician at Southeast University, Affiliated Zhongda Hospital, recognized for his expertise in orthopedics and minimally invasive spinal interventions. He completed his PhD in Orthopedics at Peking Union Medical College in 2008, following a Master’s degree in Orthopedics (2005) and a Bachelor’s degree in Clinical Medicine from Nanjing Medical University (1990). Dr. Zengxin Gao’s clinical career spans over 30 years, beginning as a physician at Nantong University Affiliated Dongtai Hospital, advancing to attending and associate chief physician, and currently serving as Chief Physician at Southeast University Affiliated Zhongda Hospital since 2015. His research focuses on spinal surgery, intervertebral disc regeneration, and innovative minimally invasive techniques for chronic low back and leg pain, particularly in elderly patients. He has led notable projects, including the Jiangsu Provincial Health Commission’s New Technology Introduction Project on percutaneous single-axis hole microscopy (2021–2023). Dr. Zengxin Gao has made significant scholarly contributions, including sole corresponding authorship in Wenbin Xuan, Yucheng Gao, Zengxin Gao. Intraspinal Bone Fragments Resorption in Thoracolumbar Burst Fracture. JAMA Neurol. 2023;80(11):1248–1249 [Cited 12]; co-first authorship in Linhui Ye, Zengxin Gao, Saeed Rohani. Intervertebral disk regeneration in a rat model by allopurinol-loaded Chitosan/alginate hydrogel. Biomol Biomed. 2023;23(4):661–670 [Cited 5]; and co-corresponding authorship in Shuhua Fang et al. Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskelet Disord. 2024;25:5 [Cited 3]. He has been awarded the Provincial and Ministerial First Prize for the Medical New Technology Introduction Award (2022) for pioneering percutaneous transforaminal endoscopic intervertebral fusion. Dr. Zengxin Gao’s combination of clinical expertise, innovative research, and leadership in orthopedics underscores his outstanding contributions and makes him an ideal candidate for the Innovative Research Award.

Profile: Scopus

Featured Publications

• Xuan, W., Gao, Y., & Gao, Z. (2023). Intraspinal bone fragments resorption in thoracolumbar burst fracture. JAMA Neurology, 80(11), 1248–1249.
https://doi.org/10.1001/jamaneurol.2023.2901

• Ye, L., Gao, Z., & Rohani, S. (2023). Intervertebral disk regeneration in a rat model by allopurinol-loaded chitosan/alginate hydrogel. Biomolecules and Biomedicine, 23(4), 661–670.
https://doi.org/10.17305/bjbms.2023.8535

• Fang, S., Cao, D., Wu, Z., Chen, J., Huang, Y., Shen, Y., & Gao, Z. (2024). Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskeletal Disorders, 25(1), 5.
https://doi.org/10.1186/s12891-023-07172-0

• Gao, Z., Lin, Y., Wu, Z., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2020). LncRNA SNHG6 can regulate the proliferation and apoptosis of rat degenerate nucleus pulposus cells via regulating the expression of miR-101-3p. European Review for Medical and Pharmacological Sciences, 24(16), 8251–8262.
https://doi.org/10.26355/eurrev_202008_22592

• Gao, Z., Lin, Y., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2019). Sinomenine ameliorates intervertebral disc degeneration via inhibition of apoptosis and autophagy in vitro and in vivo. American Journal of Translational Research, 11(9), 5956–5966.
https://www.ajtr.org/files/ajtr0094769.pdf

Sahar Issa | Health Professions | Best Researcher Award

Prof. Dr. Sahar Issa | Health Professions | Best Researcher Award

Faculty of medicine, Alexandria University | Egypt

Dr. Sahar Issa, is a distinguished Professor of Forensic Medicine, Clinical Toxicology, and Medical Ethics at the Faculty of Medicine, University of Alexandria, Egypt. She earned her Ph.D. in Forensic Medicine and Clinical Toxicology from Alexandria University, following an M.Sc. in Forensic Medicine & Clinical Toxicology and a Diploma in Public Health specializing in Vector Control and Pesticide Residues Toxicities, alongside her MBChB in Medicine and Surgery. Over her extensive academic career, Dr. Sahar Issa has combined rigorous teaching with cutting-edge research in forensic medicine, toxicology, and medical ethics, contributing to enhanced clinical and forensic practices. Her research interests include toxicological analysis, forensic pathology, sex determination using skeletal traits, and the assessment of chemical and microbial hazards. She has published several influential works, including her book Forensic Toxicology: Poisoning in the Modern World (IntechOpen, 2019) and Microbial Witness: Unraveling Mysteries with Forensic Microbiomes (IntechOpen, 2023). Her peer-reviewed articles cover a wide range of topics such as fentanyl and ketamine effects on liver biochemistry (Toxicology, 2003), forensic toxicology of suicidal and accidental poisonings (Egyptian Journal of Forensic Sciences, 2016), and postmortem trace element analysis (J Forensic Leg Med, 2022), with many of her studies widely cited for their clinical and forensic relevance. Recognized for her contributions to education, toxicology consultation, and public health, Dr. Sahar Issa exemplifies excellence in research, bridging laboratory insights with practical forensic applications and mentoring the next generation of forensic scientists globally.

Profile: Google Scholar | ORCID | LinkedIn

Featured Publications

Hafez, E. M., Issa, S. Y., Ai-Mazroua, M. K., Ibrahim, K. T., & Rahman, S. M. A. (2016). The neonicotinoid insecticide imidacloprid: A male reproductive system toxicity inducer-human and experimental study.

Hafez, M. E., Issa, Y. S., & Abdel Rahman, M. S. (2015). Parenchymatous toxicity of tramadol: Histopathological and biochemical study. Journal of Alcohol and Drug Dependence, 3(5), 225.

Issa, S. Y., Khanfour, A. A., & Kharoshah, M. (2016). A model for stature estimation and sex prediction using percutaneous ulnar and radial lengths in autopsied adult Egyptians. Egyptian Journal of Forensic Sciences, 6(2), 84–89.

Ibrahim, S. Y. (2016). Determination of heavy metals and other toxic ingredients in henna (Lawsonia inermis). Journal of Environmental & Analytical Toxicology, 6(3), 9.

Cebolla, S. G., [et al.]. (2018). Fully automated forensic routine dried blood spot screening for workplace testing. Journal of Analytical Toxicology, 43(2), 1–11.

Issa, S. Y., Hafez, E. M., El-Banna, A. S., Abdel Rahman, S. M., AlMazroua, M. K., … [et al.]. (2018). Baclofen systemic toxicity: Experimental histopathological and biochemical study. Human & Experimental Toxicology, 37(4), 431–441.

Zagloul, N. M., Farghaly, R. M., ELKhatib, H., Issa, S. Y., & El-Zoghby, S. M. (2022). Technology facilitated sexual violence: A comparative study between working and non-working females in Egypt before and during the COVID-19 pandemic. Egyptian Journal of Forensic Sciences, 12(1), 21.

Alalawi, S., Issa, S. T., Takshe, A. A., & ElBarazi, I. (2022). A review of the environmental implications of the COVID-19 pandemic in the United Arab Emirates. Environmental Challenges, 8, 100561.

Eddine, N. N., Noisel, N., Dieme, D., Asmar, M. K., Issa, S. T., & Bouchard, M. (2022). Multi-matrix biomonitoring approach to assess exposure to metals and trace elements in the Lebanese population and associations with drinking water consumption. Environmental Research, 214, 113982.

Alfonso Colorado Casado de Amezua | Medicine and Health Sciences | Forensic Science Communication Award

Mr. Alfonso Colorado Casado de Amezua | Medicine and Health Sciences | Forensic Science Communication Award

Institute of Legal Medicine and Forensic Sciences of Valencia | Spain

Mr. Alfonso Colorado Casado de Amezúa is a highly respected forensic physician whose career demonstrates a profound commitment to advancing forensic science, medico-legal education, and public communication of specialized knowledge. Currently serving as Director of the Institute of Legal Medicine and Forensic Sciences of Valencia, he has built a distinguished professional record over more than fifteen years, holding key roles across Spain in Catalonia, Albacete, Cuenca, Guadalajara, and Valencia. His leadership has been pivotal in forensic pathology and disaster victim identification, where he has developed and applied protocols for managing mass casualty events with precision and compassion. Alongside his clinical and administrative responsibilities, Mr. Alfonso Colorado Casado de Amezúa has played a central role in training the next generation of forensic professionals. As adjunct professor at the University CEU-Cardenal Herrera in Valencia and Castellón, and as lecturer in numerous specialized courses for forensic doctors, law enforcement, and emergency response teams, he has demonstrated an exceptional ability to communicate complex forensic concepts with clarity and authority. His scientific contributions, including publications in the Revista Española de Medicina Legal and CorSalud, have provided valuable insights into sudden cardiac death and forensic practices in disaster contexts, strengthening both research and applied forensic work. As organizer and speaker in national training programs, he has further enhanced the visibility of forensic medicine and ensured the dissemination of best practices across Spain. By uniting research, practice, and communication, Mr. Colorado embodies the mission of forensic science to serve justice and society, making him an outstanding nominee for the Forensic Science Communication Award.

Profile: ORCID

Featured Publications

Colorado Casado de Amezúa, A., Garrido-Lestache López-Belmonte, E., & Giner Blasco, J. (2025). Medical forensic response during the flood in Valencia (Spain), October 29th, 2024 [Actuación médico-forense durante la riada en Valencia (España) el 29 de octubre de 2024]. Revista Española de Medicina Legal. Advance online publication.

Colorado, A., & Fernández Bayón, J. (2009). Síndrome de Loeys-Dietz. Diagnóstico diferencial en muerte súbita por disección aórtica. Revista Española de Medicina Legal, 35(2), 67–71.